Introduction: The Scientific Need for Multiplex Strategies Advances in biomarker technologies have transformed how researchers investigate immune responses, disease biology, and therapeutic mechanisms. Traditional single-analyte assays, such as ELISA, remain valuable tools for focused questions. However, complex biological systems rarely operate through a single pathway or molecule. Instead, networks of cytokines, chemokines, and other signaling […]
As the landscape of Alzheimer’s disease (AD) research continues to evolve, there is increasing demand for blood-based biomarkers that offer both precision and scalability. Among these, brain-derived phosphorylated tau (BDpTau) markers are gaining momentum for their unique ability to measure tau proteins sourced exclusively from the brain. These biomarkers address a critical limitation of conventional […]
Introduction Cancer immunotherapies harness the patient’s immune system, but individual responses vary widely. Measuring cytokines – small immune‐signaling proteins – can reveal how a patient’s immune system is reacting to therapy. Measuring cytokines such as interleukin‑6 (IL‑6) and interferon‑γ (IFN‑γ) reveals critical biomarkers involved in anti‑tumor activity, while their dysregulated release can cause life‑threatening cytokine […]
Introduction to Cytokine Release Syndrome (CRS) Cytokine Release Syndrome (CRS) is a potentially life-threatening inflammatory response triggered by certain immunotherapies, such as CAR-T cell therapy, monoclonal antibodies, and immune checkpoint inhibitors. Characterized by an overproduction of pro-inflammatory cytokines, CRS requires timely diagnosis and intervention to prevent severe complications, including multi-organ failure. Understanding the underlying mechanisms, […]
Long COVID, also known as post-COVID syndrome, presents significant challenges due to its persistent symptoms—such as fatigue, cognitive impairment, and respiratory difficulties—that can linger long after the initial infection has resolved. Understanding this complex condition requires advanced diagnostic tools to uncover its underlying biological mechanisms. At Eve Technologies, our CLIA-certified Long COVID Vascular Health Panel […]